Monitoring and data analysis will continue over the next three to four months, and we hope to present final results at the San Antonio Breast Cancer ...
News
- Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and ...
- Dateline Rice for May 19, 2025 (Weekend Edition)
... biomedical security. ... An article mentions that Rice's baseball team was swept in its three-game series against the University of Texas at San Antonio ...
- The National Observer: Airports, airlines prepare for travel surge - The Business Journals
San Antonio International Airport officials last week offered city ... Biotech sector maps out its next half-century. It was nearly 50 years ...
- Anixa Reports 70% Success in Cancer Vaccine Trial, Advances CAR-T Therapy Program
Key upcoming milestones include final Phase 1 data presentation at the San Antonio Breast Cancer Symposium in December 2025, FDA interactions for ...
- RTX's Raytheon delivers 250th RAM launcher to U.S. Navy - Stock Titan
Skye Bioscience Establishes Partnership with Arecor Therapeutics ... ... The system will be installed on the USS Pittsburgh, a San Antonio-class ...